These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 28928804)
1. Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma. Yoshihara S; Kikuchi Y; Saitou M; Yanagawa S; Kanno N; Igarashi H; Fukuda H; Iimura A; Abe T; Yamada Y; Andou T; Arisaka O Exp Ther Med; 2017 Oct; 14(4):3233-3238. PubMed ID: 28928804 [TBL] [Abstract][Full Text] [Related]
2. Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study. Hosoya K; Masuno S; Hashiguchi K; Okubo K J Drug Assess; 2014; 3(1):51-9. PubMed ID: 27536454 [TBL] [Abstract][Full Text] [Related]
3. Delay of onset of symptoms of Japanese cedar pollinosis by treatment with a leukotriene receptor antagonist. Gotoh M; Suzuki H; Okubo K Allergol Int; 2011 Dec; 60(4):483-9. PubMed ID: 21778814 [TBL] [Abstract][Full Text] [Related]
4. Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber. Endo S; Gotoh M; Okubo K; Hashiguchi K; Suzuki H; Masuyama K J Drug Assess; 2012; 1(1):48-54. PubMed ID: 27536428 [TBL] [Abstract][Full Text] [Related]
5. Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists. Sasaki K; Okamoto Y; Yonekura S; Okawa T; Horiguchi S; Chazono H; Hisamitsu M; Sakurai D; Hanazawa T; Okubo K Int Arch Allergy Immunol; 2009; 149(4):350-8. PubMed ID: 19295239 [TBL] [Abstract][Full Text] [Related]
6. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber. Wakabayashi K; Hashiguchi K; Kanzaki S; Fujioka M; Tanaka N; Kawashima K; Suematsu K; Yamamotoya H; Iwasaki M; Gotoh M; Horibe S; Naito K; Okubo K Allergy Asthma Proc; 2012; 33(1):102-9. PubMed ID: 22370535 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting. Yonekura S; Okamoto Y; Okubo K; Okawa T; Gotoh M; Suzuki H; Kakuma T; Horiguchi S; Hanazawa T; Konno A; Okuda M J Investig Allergol Clin Immunol; 2009; 19(3):195-203. PubMed ID: 19610262 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis. Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502 [TBL] [Abstract][Full Text] [Related]
9. Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis. Sagara H; Yukawa T; Kashima R; Okada T; Fukuda T Allergol Int; 2009 Jun; 58(2):277-87. PubMed ID: 19390239 [TBL] [Abstract][Full Text] [Related]
10. [Japanese cedar pollinosis is a risk factor for bronchial asthma in Japanese adult asthmatics]. Ueno K; Minoguchi K; Kohno Y; Oda N; Wada K; Miyamoto M; Yokoe T; Hashimoto T; Minoguchi H; Miyamoto M; Yokoe T; Hashimoto T; Minoguchi H; Tanaka A; Kokubu F; Adachi M Arerugi; 2002 Jul; 51(7):565-70. PubMed ID: 12201170 [TBL] [Abstract][Full Text] [Related]
11. Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure. Kanzaki S; Hashiguchi K; Wakabayashi KI; Suematsu K; Okubo K J Drug Assess; 2016; 5(1):15-23. PubMed ID: 27785375 [No Abstract] [Full Text] [Related]
12. Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber. Yamamoto H; Yonekura S; Sakurai D; Katada K; Inamine A; Hanazawa T; Horiguchi S; Okamoto Y Allergy Asthma Proc; 2012; 33(5):397-403. PubMed ID: 23026181 [TBL] [Abstract][Full Text] [Related]
13. [Studies on the experimental allergic rhinitis induced by Japanese cedar pollen--role of cysteinyl leukotrienes in nasal allergic symptoms]. Mizutani N Yakugaku Zasshi; 2003 Jan; 123(1):1-8. PubMed ID: 12607939 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Yamamoto H; Yamada T; Sakashita M; Kubo S; Susuki D; Tokunaga T; Ogi K; Terasawa Y; Yamashita S; Kayano Y; Masada M; Kimura Y; Fujieda S Allergy Asthma Proc; 2012; 33(2):e17-22. PubMed ID: 22525385 [TBL] [Abstract][Full Text] [Related]
15. [The effect of initial treatment by FP aqueous nasal spray in patients with Japanese cedar pollinosis]. Nakabayashi S; Suzuki N; Nakatsuka S; Ikeda K; Takasaka T; Inamura N Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1162-71. PubMed ID: 8914412 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber. Hashiguchi K; Kanzaki S; Wakabayashi K; Tanaka N; Kawashima K; Suematsu K; Tokunaga S; Ogawa K; Okubo K J Drug Assess; 2013; 2(1):94-105. PubMed ID: 27536443 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726 [TBL] [Abstract][Full Text] [Related]
18. [Onset feature and efficacy of early interventional treatment of Artemisia pollinosis]. Ouyang Y; Fan E; Li Y; Zhang L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Apr; 49(4):272-6. PubMed ID: 24931013 [TBL] [Abstract][Full Text] [Related]
19. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. Hashiguchi K; Okubo K; Wakabayashi K; Tanaka N; Watada Y; Suematsu K; Gotoh M J Drug Assess; 2012; 1(1):40-7. PubMed ID: 27536427 [TBL] [Abstract][Full Text] [Related]
20. [The immunological parameters and risk factors for pollen-induced allergic rhinitis and asthma]. Staikūniene J; Sakalauskas R Medicina (Kaunas); 2003; 39(3):244-53. PubMed ID: 12695637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]